Exact Mass: 656.3322
Exact Mass Matches: 656.3322
Found 64 metabolites which its exact mass value is equals to given mass value 656.3322
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(2R)-2-[[(2R)-2-[[(2S)-2-(Azepane-1-carbonylamino)-4-methylpentanoyl]amino]-3-(1-formylindol-3-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoic acid
PREGN-5-EN-20-ONE,3-[(6-O-B-D-GLUCOPYRANOSYL-B-D-GLUCOPYRANOSYL)OXY]-14-HYDROXY-,(3B,14B)- (9CI)
3-O-alpha-L-rhamnopyranosyl-1-O-sulfo-(25S)-ruscogenin
2alpha,3beta-dihydroxy-5alpha-pregn-16-en-20-one-3-O-beta-D-glucopyranosyl(1->4)-beta-D-galactopyranoside
Arg Arg Tyr Tyr
Arg Tyr Arg Tyr
Arg Tyr Tyr Arg
Tyr Arg Arg Tyr
Tyr Arg Tyr Arg
Tyr Tyr Arg Arg
Deferoxamine mesylate
D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Deferoxamine mesylate (Deferoxamine B mesylate) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine mesylate upregulates HIF-1α levels with good antioxidant activity. Deferoxamine mesylate also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine mesylate can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and anti-COVID-19[1][2][3][4][5].
N-{5-[acetyl(hydroxy)amino]pentyl}-N-(5-{4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanamido}pentyl)-N-hydroxybutanediamide methanesulfonate
D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents